Anti-HBc quantitative detection method and uses thereof in monitoring and controlling disease progression of chronic hepatitis B patient and in predicting therapeutic effect

: \amt\Interwoven\NRPortbl\DCC\AMT\16374362_l.docx-30/01/2018 Disclosed in the present invention are antibodies against hepatitis B core protein (Anti-HBc) quantitative detection method and the uses thereof in monitoring and controlling disease progression of a chronic hepatitis B patient and in pre...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Xu, Feihai, Ge, Shengxiang, Zhou, Wenbin, Song, Liuwei, Zhang, Jun, Weng, Zuxing, Yuan, Quan, Xia, Ningshao
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:: \amt\Interwoven\NRPortbl\DCC\AMT\16374362_l.docx-30/01/2018 Disclosed in the present invention are antibodies against hepatitis B core protein (Anti-HBc) quantitative detection method and the uses thereof in monitoring and controlling disease progression of a chronic hepatitis B patient and in predicting therapeutic effect. Anti-HBc are quantitatively detected, so that disease progression of a chronic hepatitis B patient is monitored and controlled, and the therapeutic effect on a chronic hepatitis B patient under anti-hepatitis B virus (HBV) treatment (especially, under treatment based on interferon and under treatment through anti-HBV medicine based on nucleoside or nucleotide analogues) is effectively predicted, thereby guiding the patient to reasonably select medicine.